INCYTE
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Delaware, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1801 Augustine Cut Off, Wilmington, Dela...Phone Number
(302) 498-6700Website
www.incyte.comRevenue
$5.4 BillionStock Symbol
INCYIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
21
1
2
2
2
1
About INCYTE
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia.Explore more
INCYTE Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is INCYTE your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once INCYTE has new funding data
Check if INCYTE has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at INCYTE
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if INCYTE had a recent Job posting/layoffs
Check out if INCYTE is spiking on competitors!
Earning: See what the market has to say on INCYTE recently announced quarterly report
INCYTE, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when INCYTE launches new products
Recommended Actions
Find VP level buyers at INCYTE
Find more new buyers
Compare Similar Companies to INCYTE
Compare insights from companies similar to INCYTE, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$827.1M
501-1,000
Public
$2.5B
1998
QN
Quintus NgumahVice President, Clinical Development & Chief Marketing Officer, Cos To The
Company Profile Activity
Activity Insights
INCYTE is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
INCYTE is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about INCYTE.
INCYTE Tech Stack
A closer look at the technologies used by INCYTE
See more technologies
Most Recent Scoops
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
INCYTE has more open roles in Legal than it has had at any time in the past 9 months.
Hiring Plans
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
INCYTE News & Media
2 Fast-Growing Pharmaceutical Stocks to Buy Now
Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings.Incyte (INCY): Truist Raises the Price Target to $105 as a Government Settlement Adds $246 Million to Net Sales
Incyte Corporation (NASDAQ:INCY) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 22, Truist Securities analyst Srikripa Devarakonda raised the price target on Incyte Corporation (NASDAQ:INCY) from $103 to $105, while keeping a Hold rating on the stock. Devarakonda said the target increase was partly driven by a one-time financial boost […]Here Are Monday’s Best Wall Street Analyst Research Calls: Accenture, Apple, Boyd Gaming, BWX Technologies, Conoco-Phillips, Estee Lauder, Hut 8, Incyte, SpaceX, and More
Pre-Market Stock Futures: Futures are trading mixed as we prepare to finish the last full week of the second quarter. We finished a wild holiday-shortened trading week last Thursday, as Friday was the federal Juneteenth holiday, and all major indices rebounded smartly from the Federal Reserve-induced sell-off on Wednesday. Details of the signed memorandum of ... Here Are Monday’s Best Wall Street Analyst Research Calls: Accenture, Apple, Boyd Gaming, BWX Technologies, Conoco-Phillips, Estee LaudIncyte gains $246M non-cash boost from CMS deal | INCY 8-K Filing - Stock Titan
Incyte settles with CMS over Medicaid rebates for Opzelura, reversing $246M of accruals and ending related litigation, with improved gross-to-net and updated guidance ahead.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding INCYTE
Sign Up For FreeTo access detailed company insights
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome... Read More
